Justus-Liebig-Universität Gießen

Giessen 35392

1 studies enrolling now · 6 studies all time

What they study most

Cardiovascular Diseases, Chronic Kidney Diseases, Diabetes Mellitus, Hypertension, Idiopathic Pulmonary Fibrosis, Lung Cancer, Non-squamous, Non-small Cell, Neoplasm Metastasis, Non-Small Cell Lung Cancer, Solid Tumours, Type 1 Diabetes Mellitus, Vascular Diseases

Studies at this site

• Beamion PANTUMOR-1: A Study to Test Whether Zongertinib Helps People With Advanced Cancers With HER2 Alterations — Recruiting now
• SPYRAL AFFIRM Global Study of RDN With the Symplicity Spyral RDN System in Subjects With Uncontrolled HTN — Running, not enrolling
• Beamion LUNG-1: A Study to Test Different Doses of Zongertinib in People With Different Types of Advanced Cancer (Solid Tumours With Changes in the HER2 Gene) — Running, not enrolling
• Beamion LUNG-2: A Study to Test Whether Zongertinib (BI 1810631) Helps People With Advanced Non-small Cell Lung Cancer With HER2 Mutations Compared With Standard Treatment — Running, not enrolling
• A Phase III Study to Investigate if the Study Drug Diamyd Can Preserve Insulin Production and Improve Glycemic Control in Patients Newly Diagnosed With Type 1 Diabetes — Running, not enrolling
• Macitentan Use in an Idiopathic Pulmonary Fibrosis Clinical Study — Completed